Preparation and characterization of lovastatin polymeric microparticles by coacervation-phase separation method for dissolution enhancement

Journal of Applied Polymer Science

Volumn 133, Issue 14, 2016, Pages

  Al Nimry, Suhair S ^a   Khanfar, Mai S ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

amorphous; biomedical applications; properties and characterization; separation techniques; surfactants

Indexed keywords

AMORPHOUS MATERIALS; BIOCHEMISTRY; CHARACTERIZATION; DISSOLUTION; DRUG PRODUCTS; MEDICAL APPLICATIONS; ORGANIC SOLVENTS; PARTICLE SIZE; PARTICLE SIZE ANALYSIS; PHASE SEPARATION; SOLVENTS; SURFACE ACTIVE AGENTS;

BIOMEDICAL APPLICATIONS; CHARACTERIZATION TECHNIQUES; DISSOLUTION RATES; PHYSICAL MIXTURES; POLYMERIC MICROPARTICLES; PROCESS PARAMETERS; SEPARATION METHODS; SEPARATION TECHNIQUES;

POLYMERS;

EID: 84954372262     PISSN: 00218995     EISSN: 10974628     Source Type: Journal    
DOI: 10.1002/app.43277     Document Type: Article

References (45)

1. Harvey, R. A.,;, Clark, M. A.,;, Finkel, R.,;, Rey, J. A.,;, Whalen, K., Pharmacology; Lippincott Williams and Wilkins: Philadelphia, 2012; Chapter 21, p 265.
2. Nanjwade, B. K.,;, Derkar, G. K.,;, Bechra, H. M.,;, Nanjwade, V. K.,;, Manvi, F. V., J. Nanomedic. Nanotechnol. 2011, 2, 107.
3. Patel, R. P.,;, Patel, M. M., Pharm. Tech. 2007, 2, 72.
4. Bee, T., Ingredients and process technologies for improved drug solubility. Available at: TBee @ispcorp.com.
5. Amidon, G. L.,;, Lennernäs, H.,;, Shah, V. P.,;, Crison, J. R., Pharm. Res. 1995, 12, 413.
6. Patel, M.,;, Tekade, A.,;, Gattani, S.,;, Surana, S., AAPS PharmSciTech. 2008, 9, 1262.
7. Mevacor monograph available at: http://www.rxlist.com/mevacordrug/clinicalpharmacology.htm.
8. Dixit, M.,;, Rahman, F.,;, Charyalu, N.,;, Daniel, S.,;, Rasheed, A., Int. J. Pharma. Res. Bio-Sci. (IJPRBS) 2014, 3, 237.
9. Süle, A.,;, Szente, L.,;, Csempesz, F., J. Pharm. Sci. 2009, 98, 484.
10. Mehramizi, A.,;, AsgariMonfared, E.,;, Pourfarzib, M.,;, Bayati, K.,;, Dorkoosh, F. A.,;, Rafiee-Tehrani, M., Daru 2007, 15, 71.
11. Katare, M. K.,;, Kohli, S.,;, Jain, A. P., Int. J. Pharm. Life. Sci. 2011, 2, 894.
12. Patel, R. P.,;, Patel, M. M., Pharm. Dev. Technol. 2007, 12, 21.
13. Shaikh, K.,;, Patwekar, S.,;, Payghan, S.,;, D'Souza, J., Asian J. Biomed. Pharm. Sci. 2011, 1, 24.
14. Kumar, S.,;, Nagpal, K.,;, Singh, S. K.,;, Mishra, D. N., Daru 2011, 19, 57.
15. Kulkarni, A.,;, Bhatia, M., Iranian J. Pharma. Res. (IJPR) 2009, 8, 15.
16. Saikrishna, K.,;, Kiran, S.,;, Rao, U. M.,;, Leela, K.,;, Raju, B.,;, Saindhya, K. N. S.,;, Bathini, P.,;, Narender, M.,;, Nagaraju, V.,;, Anudeep, P., Int. J. Pharm. Bio. Sci. 2014, 4, 01.
17. Mandal, S., S. Afr. Pharm. J. 2011, 78, 44.
18. Goyal, U.,;, Arora, R.,;, Aggarwal, G., Acta Pharm. 2012, 62, 357.
19. Chen, C. C.,;, Tsai, T. H.,;, Huang, Z. R.,;, Fang, J. Y., Eur. J. Pharm. Biopharm. 2010, 74, 474.
20. Suresh, G.,;, Manjunath, K.,;, Venkateswarlu, V.,; and, Satyanarayana, V., AAPS PharmSciTech. 2007, 8, http://www.aapspharmscitech.org.
21. Fricker, G.,;, Kromp, T.,;, Wendel, A.,;, Blume, A.,;, Zirkel, J.,;, Rebmann, H.,;, Setzer, C.,;, Quinkert, R. O.,;, Martin, F.,;, Müller-Goymann, C., Pharm. Res. 2010, 27, 1469.
22. kumar, A.,;, Shinde, J.,;, Harinath, N., Res. J. Pharma. Technol. (RJPT) 2011, 4, 1869.
23. SatheeshMadhav, N. V.,;, Kala, S., Int. J. PharmTech. Res. 2011, 3, 1242.
24. Barba, A. A.,;, Dalmoro, A.,;, d'Amore, M.,;, Vascello, C.,;, and Lamberti, G., J. Mater. Sci. 2014, 49, 5160.
25. Dupinder, K.,;, Seema, S., Int. Res. J. Pharm. App. Sci. 2013, 3, 197.
26. Guan, Q.,;, Chen, W.,;, Hu, X., Drug Des. Dev. Ther. 2015, 9, 791.
27. He, H.,;, Shi, B.,;, Cai, C.,;, Tang, X., Arch. Pharm. Res. 2011, 34, 1931.
28. Wang, W.,;, Nyman, J. S.,;, Moss, H. E.,;, Gutierrez, G.,;, Mundy, G. R.,;, Yang, X.,;, Elefteriou, F., J. Bone Mineral Res. (JBMR) 2010, 25, 1658.
29. Jiang, T.,;, Wu, C.,;, Gao, Y.,;, Zhu, W.,;, Wan, L.,;, Wang, Z.,;, Wang, S., Drug Dev. Ind. Pharm. 2014, 40, 252.
30. Freitas, S.,;, Merkle, H. P.,;, Gander, B., J. Control. Rel. 2005, 102, 313.
31. Shah, R. B.,;, Tawakkul, M. A.,;, Khan, M. A., AAPS PharmSciTech. 2008, 9, 250.
32. Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug, Evaluation and Research (CDER), August 2000 BP.
33. Álvarez-Lueje, A.,;, Pastine, J.,;, Squella, J. A.,;, Nuñez-Vergara, J., J. Chil. Chem. Soc. 2005, 50, 639.
34. Jyothi, N.,;, Prasanna, M.,;, Prabha, S.,;, Ramaiah, P. S.,;, Srawan, G.,;, Sakarka, S., Internet J. Nanotechnol. 2008, 3, 1.
35. Dhakar, R. C.,;, Maurya, S. D.,;, Saluja, V., J. Drug Deliv. Therapeutics (JDDT) 2012, 2, 128.
36. Sinko, P. J., In Martin's Physical Pharmacy and Pharmaceutical Sciences; Troy, D., Ed.; Lippencott Williams and Wilkins: Philadelphia, 2012; Chapter 18, p 499.
37. ® L 100 provided by Evonik Industries.
38. Technical data sheet for PEG 4000 provided by Dow Chemical Company AG.
39. Polyvinylpyrrolidone polymers brochure provided by ISP Corporation.
40. ® S 100. Info 7.3/E by Röhm GmbH & Co. KG at www.roehm.com.
41. Harrold, M., In Foye's Principles of Medicinal Chemistry;, Lemke, T. L.,;, Williams, D. A.,;, Roche, V. F.,;, Zito, S. W., Eds.; Lippencott Williams and Wilkins: Philadelphia, 2013; Chapter 25, p 827.
42. Sun, H.,;, Gong, J.,;, Wang, J., J. Chem. Eng. Data. 2005, 50, 1389.
43. Lovastatin product description. Available at: http://www.agscientific.com.
44. Patel, D. S.,;, Pipaliya, R. M.,;, Surti, N., Indian J. Pharm. Sci. 2015, 77, 290. Available at: http://www.ijpsonline.com/text.asp?2015/77/3/290/159618.
45. Al-Nimry, S. S.,;, Qandil, A. M.,;, Salem, M. S., Pharmazie 2014, 69, 874.